Skip to main content
. 2021 Jun 3;2021:7054134. doi: 10.1155/2021/7054134

Table 3.

Distribution of biomarker expressions in breast cancer patients.

Biomarker Percentage expressed (%)
bcl-2
Positive 37.9
Negative 62.1

ER
Positive 29.0
Negative 71.0

PR
Positive 10.9
Negative 89.1

HER2 overexpression
Positive 20.7
Negative 79.3

p53
Positive 36.7
Negative 63.3

Ki-67
Low (mild) 62.1
Moderate 16.5
High (severe) 21.4